ReviewIntractable & rare diseases research2020
A basic understanding of congenital extrahepatic portosystemic shunt: incidence, mechanism, complications, diagnosis, and treatment.
Review in Intractable & rare diseases research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Surgical treatment and prognosis of type II congenital extrahepatic portosystemic shunts: A single-center experience of 31 cases.Intractable & rare diseases research · 2026Article
- Congenital Portosystemic Shunts: A Review.Journal of clinical and translational hepatology · 2026Review
- Endovascular closure of a large intrahepatic portosystemic shunt in a three-month-old infant: a case report and literature review.Frontiers in pediatrics · 2026Article
- Multimodal imaging features of pelvic ectopic liver combined with type I congenital extrahepatic portosystemic shunt (Abernethy malformation) in a child: a case report.Frontiers in medicine · 2026Article
- A Mysterious Case of Recurrent Confusion: An Unusual Presentation of Congenital Intrahepatic Portosystemic Shunt.Cureus · 2025Article
- Liver bypass in the development of pathogen-associated pulmonary vascular disease: contribution of mesocaval and portosystemic shunts.American journal of physiology. Gastrointestinal and liver physiology · 2025Review
- Congenital portosystemic shunts: experience of a tertiary Tunisian referral center.AJOG global reports · 2024Article
- Incidental diagnosis of silent extrahepatic portosystemic shunt.Clinical case reports · 2024Article
- Type II Abernethy malformation with cystic fibrosis in a 12-year-old girl: A case report.World journal of clinical cases · 2023Article
- Adult-onset noncirrhotic hyperammonemic encephalopathy probably caused by splenorenal shunts.Clinical case reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extrahepatic portosystemic shunt belongs to a family of rare vascular abnormalities. The clinical importance and manifestations of this vascular abnormality range from asymptomatic cases to liver or metabolic dysfunctions of various degrees. Congenital extrahepatic portosystemic shunt, also termed as Abernethy malformation, is a very rare congenital vascular malformation in which splenomesenteric blood drains into a systemic vein, bypassing the liver through a complete or partial extrahepatic shunt. So far, limited cases of congenital extrahepatic portosystemic shunt have been reported. In this review, incidence, mechanisms, complications, diagnoses and treatments of congenital extrahepatic portosystemic shunt are described.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.